Galapagos NV (GLPG): Price and Financial Metrics


Galapagos NV (GLPG): $44.19

-0.38 (-0.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GLPG to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

GLPG Stock Price Chart Interactive Chart >

Price chart for GLPG

GLPG Price/Volume Stats

Current price $44.19 52-week high $72.11
Prev. close $44.57 52-week low $37.24
Day low $43.63 Volume 107,704
Day high $44.55 Avg. volume 110,595
50-day MA $42.38 Dividend yield N/A
200-day MA $49.73 Market Cap 2.91B

Galapagos NV (GLPG) Company Bio


Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines in areas such as cystic fibrosis, inflammation, and other indications. The company was founded in 1999 and is Mechelen, Belgium.


GLPG Latest News Stream


Event/Time News Detail
Loading, please wait...

GLPG Latest Social Stream


Loading social stream, please wait...

View Full GLPG Social Stream

Latest GLPG News From Around the Web

Below are the latest news stories about GALAPAGOS NV that investors may wish to consider to help them evaluate GLPG as an investment opportunity.

Galapagos receives transparency notification from FMR LLC

Mechelen, Belgium; 10 January 2023, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 9 January 2023 from FMR LLC, who notified that it holds 3,903,804 of Galapagos’ voting rights, consisting of 3,801,504 ordinary shares and 102,300 equivalent financial instruments. FMR LLC controls investment funds Fidelity Management & Resea

Yahoo | January 10, 2023

Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference

Mechelen, Belgium; 3 January 2023, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) will participate in the 41th Annual J.P. Morgan Healthcare Conference on January 9-12, 2023. Paul Stoffels1, CEO, will present on Monday, January 9 at 4.30 p.m. PST/7.30 p.m. ET (Tuesday, January 10 at 01.30 a.m. CET). The presentation will be a live audio webcast and can be accessed via the following link. A replay of the webcast will be available on the Galapagos’ website at https://www.glpg.com/webcasts. Abou

Yahoo | January 3, 2023

Galapagos Stock: Setting Up For Transformation (NASDAQ:GLPG)

Galapagos is setting up to transform its business after a slew of failures. Read more to see why I think GLPG will be successful in its transformation plans.

Seeking Alpha | December 30, 2022

3 Beaten-Down Drug Stocks Poised for a Turnaround in 2023

Here we present three drug and biotech stocks, VIR, GLPG and PCRX, which took a beating in 2022 but have upside potential for 2023, despite an uncertain macro environment.

Yahoo | December 28, 2022

Galapagos announces changes to Executive Committee

Mechelen, Belgium; 22 December 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced changes in the Executive Committee effective 1 January 2023. Dr. Walid Abi-Saab has decided to retire from the company as Chief Medical Officer and member of the Executive Committee, effective 31 December 2022. He will stay with Galapagos until 31 May 2023 to ensure a smooth transition. The company also announces the retirement of André Hoekema who joined Galapagos in 2005 as Chief Business Off

Yahoo | December 22, 2022

Read More 'GLPG' Stories Here

GLPG Price Returns

1-mo 1.35%
3-mo -2.84%
6-mo -13.20%
1-year -32.33%
3-year -80.81%
5-year -62.37%
YTD -0.43%
2022 -19.50%
2021 -44.30%
2020 -52.14%
2019 125.45%
2018 -2.15%

Continue Researching GLPG

Want to see what other sources are saying about Galapagos Nv's financials and stock price? Try the links below:

Galapagos Nv (GLPG) Stock Price | Nasdaq
Galapagos Nv (GLPG) Stock Quote, History and News - Yahoo Finance
Galapagos Nv (GLPG) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7808 seconds.